The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
June 5th 2023
Powered by deep learning technology, Sonic DL reportedly facilitates the acquisition of cardiac magnetic resonance imaging (MRI) scans at 12 times the speed of conventional MRI systems.
Meta-Analysis Reaffirms Benefits of O-RADS MRI for Diagnosing Indeterminate Adnexal Lesions
December 16th 2022In addition to summary sensitivity and specificity of 92 percent and 91 percent respectively for characterization of indeterminate adnexal lesions, the meta-analysis on pelvic magnetic resonance imaging (MRI) revealed higher summary malignancy rates for O-RADS MRI 4 and 5 lesions than predicted.
Could an Emerging AI Platform Supplant Traditional MRI for Assessing Prostate Cancer?
December 7th 2022The Food and Drug Administration has granted 510(k) clearance to iQuest (Avenda Health), an artificial intelligence (AI) platform that combines findings from magnetic resonance imaging (MRI), pathology reports and biopsy results to facilitate three-dimensional mapping of prostate cancer.
What BI-RADS Changes Are on the Way for Breast MRI Reporting?
December 2nd 2022In a recent lecture at the Radiological Society of North America (RSNA) conference, Wendy DeMartini, MD, discussed a variety of preliminary proposed changes to the Breast Imaging Reporting and Data System (BI-RADS) for breast magnetic resonance imaging (MRI) examinations.
Can MRI-Based Prostate Cancer Screening be a Viable Alternative to PSA Testing?
December 1st 2022In what may be the first study to assess the effectiveness of biparametric magnetic resonance imaging (MRI) for prostate cancer screening in a large cohort, researchers found that MRI screening had a significantly lower false positive rate and significantly higher positive predictive values (PPVs) than prostate-specific antigen (PSA)-based screening.
Enhancing MRI Efficiency and Quality: Can the New SIGNA Experience Have an Impact?
November 29th 2022Recently launched at the Radiological Society of North America (RSNA) conference, the SIGNA Experience reportedly features synergistic technologies and artificial intelligence (AI) advances that help improve the efficiency and quality of magnetic resonance imaging.
What an MRI Study Reveals About Low Alcohol Use During Pregnancy and Fetal Brain Structure
November 28th 2022Researchers found that even low amounts of alcohol consumption in pregnant women can lead to early and diffuse structural changes in brain regions related to key functions including language development.
Philips Launches AI-Enabled 'Visualization Workspace' at RSNA
November 28th 2022Offering more than 70 clinical applications, the next-generation edition of the Advanced Visualization Workspace reportedly includes enhanced liver analysis and artificial intelligence (AI)-powered scoring of early brain infarction noted on computed tomography (CT) scans for patients with ischemic stroke.
Ultra-High-Resolution MRI Identifies Enlarged Perivascular Spaces in People with Migraines
November 28th 2022New magnetic resonance imaging (MRI) research suggests a significant link between deep white matter hyperintensity severity and increased quantity of enlarged perivascular spaces in the centrum semiovale among people with migraines.
Brain MRI Study Shows 'Significant Abnormalities' Up to Six Months After COVID-19
November 21st 2022COVID-19 may cause changes in the brain stem and frontal lobe that could lead to fatigue, impacts in motor signal processing, insomnia, and depression, according to emerging research recently presented at the Radiological Society of North America (RSNA) annual conference in Chicago.
What a New MRI Study Reveals About Brain Aging and Racial Disparities
November 17th 2022New magnetic resonance imaging research shows earlier brain aging in middle-age Black individuals with researchers suggesting that cumulative exposure to stress over socioeconomic and environmental adversities may be a key contributing factor.
New MRI Study Identifies Signature White Matter Connectivity Patterns in People with Autism
November 14th 2022Emerging research has revealed findings on diffusion magnetic resonance imaging (MRI) correlational tractography that may help neuroradiologists differentiate between autism spectrum disorder (ASD) and developmental coordination disorder (DCD).
Current Insights on AI, Breast Cancer Screening and the FDA
November 8th 2022In a recently published article, researchers from Yale University discuss the pros and cons of current FDA regulations as they apply to the clearance and use of adjunctive artificial intelligence (AI) software with conventional breast cancer screening modalities such as mammography.
Radiotherapy for Prostate Cancer: Study Says MRI Guidance Significantly Reduces GU and GI Toxicities
October 28th 2022For patients undergoing stereotactic body radiotherapy (SBRT) for prostate cancer, the acute genitourinary (GU) toxicity rate associated with the procedure was 19 percent lower with magnetic resonance imaging (MRI) guidance in comparison to computed tomography (CT) guidance, according to new research presented recently at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Transvaginal Ultrasound or MRI: Which is More Effective in Evaluating Endometrial Cancer?
October 26th 2022In a new study looking at pre-operative assessment of low-grade endometrial cancer, researchers found that while magnetic resonance imaging (MRI) had 20 percent higher specificity than transvaginal ultrasound for deep myometrial invasion, there was no difference in sensitivity.
Study Suggests Shorter Duration of Radiation Therapy is Effective for High-Risk Prostate Cancer
October 24th 2022Five weeks of radiation therapy is just as effective as eight weeks of radiation treatment for men with high-risk prostate cancer, according to new research presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting.